*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| D6481 - Anemia due to antineoplastic chemotherapy - as a primary diagnosis code | D6481 - Anemia due to antineoplastic chemotherapy - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.02 | |
| Readmission Rate (%) | 35.04 | |
| Unplanned Readmission Rate (%) | 23.79 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 802: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 803: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 201,938 | ||||
| Total Hospitalizations with ICD D6481 - Anemia due to antineoplastic chemotherapy | 3,811 | ||||
| DRG Share of Total Hospitalizations | 0.61 | ||||
| % of Total ICD D6481 - Anemia due to antineoplastic chemotherapy in DRG | 70.76 | ||||
| Avg LOS at DRG | 3.4 | ||||
| Avg LOS with ICD D6481 - Anemia due to antineoplastic chemotherapy | 2.62 | ||||
| Readmission Rate at DRG | 26.55 | ||||
| Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 31.17 | ||||
| Unplanned Readmission Rate at DRG | 21.29 | ||||
| Unplanned Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 22.92 | ||||
| Total Medicare payments at DRG | $1,046,791,335 | ||||
| Total Medicare payments with ICD D6481 - Anemia due to antineoplastic chemotherapy | $19,177,890 | ||||
| Total Medicare payment per Day at DRG | $1,523 | ||||
| Total Medicare payment per Day with ICD D6481 - Anemia due to antineoplastic chemotherapy | $1,918 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,184 | ||||
| Total Medicare payment per Hospitalization with ICD D6481 - Anemia due to antineoplastic chemotherapy | $5,032 | ||||
| Total Medicare Charges at DRG | $5,572,284,000 | ||||
| Total Medicare Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $92,720,685 | ||||
| Avg Charges at DRG | $27,594 | ||||
| Avg Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $24,330 | ||||
| Mortality Rate at DRG | 0.31 | ||||
| Mortality Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 0.29 | ||||
| SNF Discharge Rate at DRG | 12.45 | ||||
| SNF Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 9.26 | ||||
| Home Discharge Rate at DRG | 66.72 | ||||
| Home Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 65.68 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| VIRTUA VOORHEES HOSPITAL | 100 BOWMAN DR | VOORHEES | NJ | 08043 | 23 |
| COOPER UNIVERSITY HEALTH CARE | 1 COOPER PLZ | CAMDEN | NJ | 08103 | 22 |
| ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 20 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD D6481 - Anemia due to antineoplastic chemotherapy | 8,920 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD D6481 - Anemia due to antineoplastic chemotherapy in DRG | 8.65 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD D6481 - Anemia due to antineoplastic chemotherapy | 6.97 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 29.87 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 20.93 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD D6481 - Anemia due to antineoplastic chemotherapy | $108,513,078 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD D6481 - Anemia due to antineoplastic chemotherapy | $1,745 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD D6481 - Anemia due to antineoplastic chemotherapy | $12,165 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $594,345,250 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $66,631 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 10.53 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 14.81 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 32.58 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 417,755 | ||||
| Total Hospitalizations with ICD D6481 - Anemia due to antineoplastic chemotherapy | 2,358 | ||||
| DRG Share of Total Hospitalizations | 1.27 | ||||
| % of Total ICD D6481 - Anemia due to antineoplastic chemotherapy in DRG | 2.29 | ||||
| Avg LOS at DRG | 3.9 | ||||
| Avg LOS with ICD D6481 - Anemia due to antineoplastic chemotherapy | 4.29 | ||||
| Readmission Rate at DRG | 16.53 | ||||
| Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 27.1 | ||||
| Unplanned Readmission Rate at DRG | 11.52 | ||||
| Unplanned Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 20.17 | ||||
| Total Medicare payments at DRG | $2,493,587,688 | ||||
| Total Medicare payments with ICD D6481 - Anemia due to antineoplastic chemotherapy | $15,263,643 | ||||
| Total Medicare payment per Day at DRG | $1,529 | ||||
| Total Medicare payment per Day with ICD D6481 - Anemia due to antineoplastic chemotherapy | $1,510 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,969 | ||||
| Total Medicare payment per Hospitalization with ICD D6481 - Anemia due to antineoplastic chemotherapy | $6,473 | ||||
| Total Medicare Charges at DRG | $11,318,800,289 | ||||
| Total Medicare Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $78,986,670 | ||||
| Avg Charges at DRG | $27,094 | ||||
| Avg Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $33,497 | ||||
| Mortality Rate at DRG | 0.87 | ||||
| Mortality Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 0.59 | ||||
| SNF Discharge Rate at DRG | 17.03 | ||||
| SNF Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 7.59 | ||||
| Home Discharge Rate at DRG | 53.31 | ||||
| Home Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 64.42 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 310,318 | ||||
| Total Hospitalizations with ICD D6481 - Anemia due to antineoplastic chemotherapy | 1,662 | ||||
| DRG Share of Total Hospitalizations | 0.94 | ||||
| % of Total ICD D6481 - Anemia due to antineoplastic chemotherapy in DRG | 1.61 | ||||
| Avg LOS at DRG | 3.19 | ||||
| Avg LOS with ICD D6481 - Anemia due to antineoplastic chemotherapy | 3.68 | ||||
| Readmission Rate at DRG | 20.19 | ||||
| Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 30.33 | ||||
| Unplanned Readmission Rate at DRG | 13.62 | ||||
| Unplanned Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 21.46 | ||||
| Total Medicare payments at DRG | $1,415,392,709 | ||||
| Total Medicare payments with ICD D6481 - Anemia due to antineoplastic chemotherapy | $8,014,840 | ||||
| Total Medicare payment per Day at DRG | $1,431 | ||||
| Total Medicare payment per Day with ICD D6481 - Anemia due to antineoplastic chemotherapy | $1,309 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,561 | ||||
| Total Medicare payment per Hospitalization with ICD D6481 - Anemia due to antineoplastic chemotherapy | $4,822 | ||||
| Total Medicare Charges at DRG | $7,113,640,596 | ||||
| Total Medicare Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $46,412,402 | ||||
| Avg Charges at DRG | $22,924 | ||||
| Avg Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $27,926 | ||||
| Mortality Rate at DRG | 0.63 | ||||
| Mortality Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | NA | ||||
| SNF Discharge Rate at DRG | 19.76 | ||||
| SNF Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 12.21 | ||||
| Home Discharge Rate at DRG | 50.47 | ||||
| Home Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 53.79 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 11,287 | ||||
| Total Hospitalizations with ICD D6481 - Anemia due to antineoplastic chemotherapy | 1,266 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD D6481 - Anemia due to antineoplastic chemotherapy in DRG | 1.23 | ||||
| Avg LOS at DRG | 8.09 | ||||
| Avg LOS with ICD D6481 - Anemia due to antineoplastic chemotherapy | 7.21 | ||||
| Readmission Rate at DRG | 63.47 | ||||
| Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 68.33 | ||||
| Unplanned Readmission Rate at DRG | 16.01 | ||||
| Unplanned Readmission Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 14.93 | ||||
| Total Medicare payments at DRG | $252,996,223 | ||||
| Total Medicare payments with ICD D6481 - Anemia due to antineoplastic chemotherapy | $25,320,148 | ||||
| Total Medicare payment per Day at DRG | $2,772 | ||||
| Total Medicare payment per Day with ICD D6481 - Anemia due to antineoplastic chemotherapy | $2,772 | ||||
| Total Medicare payment per Hospitalization at DRG | $22,415 | ||||
| Total Medicare payment per Hospitalization with ICD D6481 - Anemia due to antineoplastic chemotherapy | $20,000 | ||||
| Total Medicare Charges at DRG | $1,139,315,524 | ||||
| Total Medicare Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $105,864,732 | ||||
| Avg Charges at DRG | $100,941 | ||||
| Avg Charges with ICD D6481 - Anemia due to antineoplastic chemotherapy | $83,621 | ||||
| Mortality Rate at DRG | 3.42 | ||||
| Mortality Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 1.66 | ||||
| SNF Discharge Rate at DRG | 9.94 | ||||
| SNF Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 11.3 | ||||
| Home Discharge Rate at DRG | 62.95 | ||||
| Home Discharge Rate with ICD D6481 - Anemia due to antineoplastic chemotherapy | 61.22 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 2,383 |
| HACKENSACK UNIVERSITY MEDICAL CENTER | 30 PROSPECT AVE | HACKENSACK | NJ | 07601 | 1,226 |
| BEAUMONT HOSPITAL ROYAL OAK | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073 | 506 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. LORI ANN LESLIE | 1515 HOLCOMBE BLVD, UNIT 463 | HOUSTON | TX | 77030 | 144 |
| Dr. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 133 |
| Dr. MICHAEL PATTEN CARROLL | 1020 29TH ST | SACRAMENTO | CA | 95816 | 100 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. LORI ANN LESLIE | 1515 HOLCOMBE BLVD, UNIT 463 | HOUSTON | TX | 77030 | 220 |
| Dr. TATYANA A FELDMAN | 92 2ND ST | HACKENSACK | NJ | 07601 | 188 |
| Dr. MICHAEL PATTEN CARROLL | 1020 29TH ST | SACRAMENTO | CA | 95816 | 121 |